Westside Investment Management Inc. Acquires 2,800 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Westside Investment Management Inc. raised its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 43.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,200 shares of the health services provider’s stock after purchasing an additional 2,800 shares during the quarter. Westside Investment Management Inc.’s holdings in Teladoc Health were worth $84,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of TDOC. American Century Companies Inc. increased its holdings in shares of Teladoc Health by 31.0% in the second quarter. American Century Companies Inc. now owns 136,351 shares of the health services provider’s stock valued at $1,334,000 after purchasing an additional 32,240 shares in the last quarter. Vanguard Personalized Indexing Management LLC acquired a new stake in shares of Teladoc Health in the 2nd quarter valued at $133,000. Hsbc Holdings PLC raised its position in shares of Teladoc Health by 38.2% during the second quarter. Hsbc Holdings PLC now owns 392,150 shares of the health services provider’s stock worth $3,862,000 after acquiring an additional 108,307 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its stake in shares of Teladoc Health by 209.8% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock valued at $49,000 after acquiring an additional 3,396 shares during the period. Finally, Canada Pension Plan Investment Board boosted its holdings in Teladoc Health by 13.4% in the second quarter. Canada Pension Plan Investment Board now owns 328,900 shares of the health services provider’s stock valued at $3,217,000 after acquiring an additional 38,800 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Stock Up 4.0 %

Shares of NYSE TDOC opened at $9.88 on Thursday. Teladoc Health, Inc. has a 52 week low of $6.76 and a 52 week high of $21.74. The stock has a 50 day moving average price of $9.97 and a 200 day moving average price of $9.03. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. Equities analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Activity

In other news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.95% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on TDOC shares. Deutsche Bank Aktiengesellschaft upped their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Barclays upped their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. The Goldman Sachs Group initiated coverage on Teladoc Health in a research note on Friday, November 15th. They set a “buy” rating and a $14.00 price objective for the company. Evercore ISI increased their target price on Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $13.00 price target (up from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $12.24.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.